Loading
Formation Bio
Formation Bio is an AI-native pharmaceutical company based in New York, NY, focused on transforming drug development. Founded in 2016, the company aims to expedite the clinical trial process by utilizing proprietary technology and artificial intelligence. Rather than discovering new molecules, Formation Bio specializes in accelerating the clinical development of assets acquired from other pharmaceutical and biotech firms. The company offers a technology platform that enhances clinical trial design, patient recruitment, and medical writing through AI and large language models. Formation Bio also deploys certified research coordinators to establish clinical trial sites within existing healthcare practices, improving trial efficiency and data quality. Its therapeutic focus includes areas such as atopic dermatitis, chronic hand eczema, and knee osteoarthritis. With significant backing from investors like Andreessen Horowitz and Sanofi, Formation Bio has raised over $600 million in funding and is recognized for its innovative approach to drug development.
Funding
Every round, secondary, debt facility or acquisition involving Formation Bio that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
$39M